Real world. Real answers. REAL-PE.
The largest real-world and near real-time dataset evaluating the EKOS system vs. Inari Medical’s™ FlowTriever™ system in PE interventions.
A reputation built on data
No pulmonary embolism interventional therapy has been studied as much as EKOS. EKOS is the only interventional device to treat PE that provides efficacy and safety data with long-term outcomes. The evidence is in the data—and in the over 100,000 patients who have benefitted from the procedure.
Safety or efficacy is not a choice
You can have both with EKOS. See highlights and detailed data points behind some of the most critical studies in PE interventional treatment.
The OPTALYSE trial results
The SEATTLE II trial results
The ULTIMA trial results
The future of EKOS clinical evidence
With the goal of gaining a deeper understanding of intervention for treating PE, Boston Scientific continues to invest in clinical studies.
HI-PEITHO represents the first-ever large-scale transatlantic, multi-center, prospective, randomized, controlled trial for an interventional device in pulmonary embolism (PE). It has been designed to address critical gaps in clinical evidence by comparing the clinical benefit of intervention with EKOS vs anticoagulation alone.